muscle loss on glp 1 GLP-1 weight and gain Study finds GLP-1 receptor agonists

Novo Nordisk, the Danish pharma company behind several GLP-1RA drugs (including Ozempic/Wegovy and Saxenda) grew its sales by over 30% in 2023, and its share price rose by over 70% in the last year, making it the most valuable European company by market capitalization

Hypoglycaemia , or low blood sugar is more common in people taking insulin or certain diabetes medications, but it can happen to those using GLP-1 injections like semaglutide (Wegovy) or tirzepatide (Mounjaro) for weight loss too

The Noom program has comprehensive data on patient health, injection dates, side effects, and weight-loss speed, and we bring that data to bear to personalize the dosing to maximize outcomes and adherence not just to the medication, but to our Noom microhabits program. Fear of side effects has kept many eligible users from trying GLP-1 medications, but for others, the bigger barrier is cost

Most patients report noticeable improvements in energy, stress tolerance, and sleep quality after 8 to 12 weeks of consistent use, which often coincides with the timeframe for metabolic shifts

Survodutide is a novel dual-action drug designed to treat obesity and related metabolic conditions

Medication Safety in Breastfeeding